Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Sponsor: Galderma R&D
Summary
This is a randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0112 for cheek augmentation and correction of midface contour deficiencies. Approximately 326 subjects will be randomized (1:1) to either treatment with GP0112 or Juvéderm Voluma XC(also known as Juvéderm Voluma with lidocaine).
Official title: A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
326
Start Date
2026-11
Completion Date
2028-08
Last Updated
2026-11-02
Healthy Volunteers
Yes
Interventions
GP0112
Injectable gel
Juvéderm Voluma XC
Injectable gel
Locations (1)
Galderma Investigational Site #6347
Chengdu, China